Annual ROE
-41.04%
-21.34%-108.32%
December 31, 2022
Summary
- As of February 10, 2025, TALS annual return on equity is -41.04%, with the most recent change of -21.34% (-108.32%) on December 31, 2022.
- During the last 3 years, TALS annual ROE has fallen by -147.20% (-138.66%).
Performance
TALS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-43.66%
-1.84%-4.40%
June 30, 2023
Summary
- As of February 10, 2025, TALS quarterly return on equity is -43.66%, with the most recent change of -1.84% (-4.40%) on June 30, 2023.
- Over the past year, TALS quarterly ROE has dropped by -16.49% (-60.69%).
Performance
TALS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TALS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -108.3% | -60.7% |
| 3 y3 years | -138.7% | - |
| 5 y5 years | -138.7% | - |
TALS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +108.3% | at low | +90.7% | at low |
| 5 y | 5-year | -138.7% | at low | -168.0% | +27.3% |
| alltime | all time | -138.7% | at low | -168.0% | +27.3% |
Talaris Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -43.66%(+4.4%) |
| Mar 2023 | - | -41.82%(+14.9%) |
| Dec 2022 | -41.04%(+108.3%) | -36.41%(+14.4%) |
| Sep 2022 | - | -31.84%(+17.2%) |
| Jun 2022 | - | -27.17%(+18.6%) |
| Mar 2022 | - | -22.90%(-13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -19.70%(-133.1%) | -26.60%(-27.8%) |
| Sep 2021 | - | -36.84%(-33.7%) |
| Jun 2021 | - | -55.57%(-186.6%) |
| Mar 2021 | - | 64.19%(+7.8%) |
| Dec 2020 | 59.52%(-43.9%) | - |
| Dec 2020 | - | 59.52% |
| Dec 2019 | 106.16% | - |
FAQ
- What is Talaris Therapeutics annual return on equity?
- What is the all time high annual ROE for Talaris Therapeutics?
- What is Talaris Therapeutics annual ROE year-on-year change?
- What is Talaris Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Talaris Therapeutics?
- What is Talaris Therapeutics quarterly ROE year-on-year change?
What is Talaris Therapeutics annual return on equity?
The current annual ROE of TALS is -41.04%
What is the all time high annual ROE for Talaris Therapeutics?
Talaris Therapeutics all-time high annual return on equity is 106.16%
What is Talaris Therapeutics annual ROE year-on-year change?
Over the past year, TALS annual return on equity has changed by -21.34% (-108.32%)
What is Talaris Therapeutics quarterly return on equity?
The current quarterly ROE of TALS is -43.66%
What is the all time high quarterly ROE for Talaris Therapeutics?
Talaris Therapeutics all-time high quarterly return on equity is 64.19%
What is Talaris Therapeutics quarterly ROE year-on-year change?
Over the past year, TALS quarterly return on equity has changed by -16.49% (-60.69%)